ED
AMCR icon

Exane Derivatives’s Amcor AMCR Stock Holding History

Exane Derivatives’s Portfolio AMCR Stock Details AMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.73K Sell
28
-1,252
-98% -$77.4K ﹤0.01% 453
2022
Q1 		$72.5K Buy
1,280
+18
+1% +$1.05K 0.02% 513
2021
Q4 		$75.8K Buy
1,262
+87
+7% +$5.16K 0.02% 459
2021
Q3 		$68.1K Sell
1,175
-398
-25% -$23.8K 0.02% 587
2021
Q2 		$90.9K Buy
1,573
+180
+13% +$10.7K 0.02% 553
2021
Q1 		$81.4K Sell
1,393
-9
-0.6% -$513 0.02% 449
2020
Q4 		$82.5K Buy
+1,402
New +$80K 0.02% 419

Other funds holding AMCR

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Exane Derivatives's AMCR Position: Q2 2022 in Review

Exane Derivatives reduced its Amcor (AMCR) stake by 98% in Q2 2022, selling an estimated $77.4K and leaving 28 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

Exane Derivatives first reported a position in AMCR in Q4 2020 and has held it in 7 quarters since. The position peaked at $90.9K in Q2 2021. 561 funds tracked by Wall St. Rank hold AMCR as of Q2 2022.

  • Exane Derivatives held 28 shares of Amcor worth $1.73K as of Q2 2022.
  • Exane Derivatives sold 1,252 Amcor shares in Q2 2022, an estimated $77.4K.
  • Amcor made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #453 holding.
  • Exane Derivatives first reported a position in Amcor in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Amcor position peaked at $90.9K in Q2 2021.
  • 561 funds tracked by Wall St. Rank held Amcor as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.